August JT - Search Results

1

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

Lin KY, Guarnieri FG, Staveley-O'Carroll KF, Levitsky HI, August JT, Pardoll DM, Wu TC. Lin KY, et al. Among authors: august jt. Cancer Res. 1996 Jan 1;56(1):21-6. Cancer Res. 1996. PMID: 8548765

2

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

Wu TC, Guarnieri FG, Staveley-O'Carroll KF, Viscidi RP, Levitsky HI, Hedrick L, Cho KR, August JT, Pardoll DM. Wu TC, et al. Among authors: august jt. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11671-5. doi: 10.1073/pnas.92.25.11671. Proc Natl Acad Sci U S A. 1995. PMID: 8524826 Free PMC article.

3

Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells.

Rowell JF, Ruff AL, Guarnieri FG, Staveley-O'Carroll K, Lin X, Tang J, August JT, Siliciano RF. Rowell JF, et al. Among authors: august jt. J Immunol. 1995 Aug 15;155(4):1818-28. J Immunol. 1995. PMID: 7636236

4

The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway.

Ruff AL, Guarnieri FG, Staveley-O'Carroll K, Siliciano RF, August JT. Ruff AL, et al. Among authors: august jt. J Biol Chem. 1997 Mar 28;272(13):8671-8. doi: 10.1074/jbc.272.13.8671. J Biol Chem. 1997. PMID: 9079699 Free article.

5

Targeting antigen-specific T cells by genetically engineered antigen presenting cells. A strategy for specific immunotherapy of autoimmune disease.

Wu JM, Wu B, Guarnieri F, August JT, Drachman DB. Wu JM, et al. Among authors: august jt. J Neuroimmunol. 2000 Jul 1;106(1-2):145-53. doi: 10.1016/s0165-5728(00)00201-0. J Neuroimmunol. 2000. PMID: 10814792 Free article.

6

The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1.

Guarnieri FG, Arterburn LM, Penno MB, Cha Y, August JT. Guarnieri FG, et al. Among authors: august jt. J Biol Chem. 1993 Jan 25;268(3):1941-6. J Biol Chem. 1993. PMID: 8420968 Free article.

7

Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.

Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW. Mao HQ, et al. Among authors: august jt. J Control Release. 2001 Feb 23;70(3):399-421. doi: 10.1016/s0168-3659(00)00361-8. J Control Release. 2001. PMID: 11182210

8

Expression of CD44 in human lung tumors.

Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, Croteau D, Yang XL, Rosada C. Penno MB, et al. Among authors: august jt. Cancer Res. 1994 Mar 1;54(5):1381-7. Cancer Res. 1994. PMID: 7509720

9

HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses.

Marques ET Jr, Chikhlikar P, de Arruda LB, Leao IC, Lu Y, Wong J, Chen JS, Byrne B, August JT. Marques ET Jr, et al. Among authors: august jt. J Biol Chem. 2003 Sep 26;278(39):37926-36. doi: 10.1074/jbc.M303336200. Epub 2003 Jun 24. J Biol Chem. 2003. PMID: 12824194 Free article.

10

CD44 expression in the stromal matrix of colorectal cancer: association with prognosis.

Furuta K, Zahurak M, Goodman SN, Hamilton SR, August JT. Furuta K, et al. Among authors: august jt. Clin Cancer Res. 1998 Jan;4(1):21-9. Clin Cancer Res. 1998. PMID: 9516948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters